ImmunoCellular Therapeutics

Latest Headlines

ImmunoCellular Therapeutics put out the word Wednesday afternoon that its dendritic cell-based vaccine for brain cancer flunked the key overall survival test in Phase II, news that swiftly wiped out more than half of the small biotech's market cap as shares instantly cratered.

THE LIBRARY: WEBINAR

At first glance, the TMF reference model seems daunting, especially for smaller companies. In this webinar, Kristen Snipes and Missy Lavinder share tips and tricks for making the process manageable based on their own recent experience implementing the model. Register today!